标题
Proteasome inhibitors in cancer therapy
作者
关键词
-
出版物
Journal of Cell Communication and Signaling
Volume 5, Issue 2, Pages 101-110
出版商
Springer Nature
发表日期
2011-01-30
DOI
10.1007/s12079-011-0121-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia
- (2010) A. M. Roccaro et al. BLOOD
- The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo
- (2010) G. Dasmahapatra et al. BLOOD
- Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model
- (2010) Ajita V. Singh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
- (2010) E. Kupperman et al. CANCER RESEARCH
- Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition
- (2010) Daisuke Tamura et al. CANCER SCIENCE
- A new target for proteasome inhibitors: FoxM1
- (2010) Andrei L Gartel EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ubiquitin ligase complexes: from substrate selectivity to conjugational specificity
- (2009) Vanja Nagy et al. BIOLOGICAL CHEMISTRY
- Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells
- (2009) C. P. Miller et al. BLOOD
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
- (2009) Eric Sanchez et al. BRITISH JOURNAL OF HAEMATOLOGY
- The vital link between the ubiquitin–proteasome pathway and DNA repair: Impact on cancer therapy
- (2009) Akira Motegi et al. CANCER LETTERS
- A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies
- (2009) O. A. O'Connor et al. CLINICAL CANCER RESEARCH
- Proteasome proteolytic profile is linked to Bcr-Abl expression
- (2009) Lisa J. Crawford et al. EXPERIMENTAL HEMATOLOGY
- Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)
- (2009) Han-Jie Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells
- (2009) Azhar R. Hussain et al. LEUKEMIA & LYMPHOMA
- Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas
- (2009) Ioannis P. Gialmanidis et al. LUNG CANCER
- Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction
- (2009) S Baritaki et al. ONCOGENE
- FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation
- (2009) Emilios Gemenetzidis et al. PLoS One
- Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
- (2008) Deborah J. Kuhn et al. BLOOD
- Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA
- (2008) S. T. Nawrocki et al. BLOOD
- Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
- (2008) Nuran Bektas et al. BMC CANCER
- Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells
- (2008) C. M. Sloss et al. CLINICAL CANCER RESEARCH
- Mechanisms of proteasome inhibitor action and resistance in cancer
- (2008) David J. McConkey et al. DRUG RESISTANCE UPDATES
- Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer
- (2008) Bruce D. Dorsey et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now